These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30503501)

  • 1. Identification of a novel SIRT7 inhibitor as anticancer drug candidate.
    Kim JH; Kim D; Cho SJ; Jung KY; Kim JH; Lee JM; Jung HJ; Kim KR
    Biochem Biophys Res Commun; 2019 Jan; 508(2):451-457. PubMed ID: 30503501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response.
    Kiran S; Oddi V; Ramakrishna G
    Exp Cell Res; 2015 Feb; 331(1):123-141. PubMed ID: 25445786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes.
    Heltweg B; Gatbonton T; Schuler AD; Posakony J; Li H; Goehle S; Kollipara R; Depinho RA; Gu Y; Simon JA; Bedalov A
    Cancer Res; 2006 Apr; 66(8):4368-77. PubMed ID: 16618762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT7-dependent deacetylation of NPM promotes p53 stabilization following UV-induced genotoxic stress.
    Ianni A; Kumari P; Tarighi S; Simonet NG; Popescu D; Guenther S; Hölper S; Schmidt A; Smolka C; Yue S; Krüger M; Fiorillo C; Vaquero A; Bober E; Braun T
    Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT7 Deacetylates STRAP to Regulate p53 Activity and Stability.
    Yu M; Shi X; Ren M; Liu L; Qi H; Zhang C; Zou J; Qiu X; Zhu WG; Zhang YE; Wang W; Luo J
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32527012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice.
    Vakhrusheva O; Smolka C; Gajawada P; Kostin S; Boettger T; Kubin T; Braun T; Bober E
    Circ Res; 2008 Mar; 102(6):703-10. PubMed ID: 18239138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT7 Is Activated by DNA and Deacetylates Histone H3 in the Chromatin Context.
    Tong Z; Wang Y; Zhang X; Kim DD; Sadhukhan S; Hao Q; Lin H
    ACS Chem Biol; 2016 Mar; 11(3):742-7. PubMed ID: 26907567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer Effects of a New SIRT Inhibitor, MHY2256, against Human Breast Cancer MCF-7 Cells via Regulation of MDM2-p53 Binding.
    Park EY; Woo Y; Kim SJ; Kim DH; Lee EK; De U; Kim KS; Lee J; Jung JH; Ha KT; Choi WS; Kim IS; Lee BM; Yoon S; Moon HR; Kim HS
    Int J Biol Sci; 2016; 12(12):1555-1567. PubMed ID: 27994519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis.
    Li H; Tian Z; Qu Y; Yang Q; Guan H; Shi B; Ji M; Hou P
    Oncogene; 2019 Jan; 38(3):345-359. PubMed ID: 30093629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
    Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
    Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage.
    Solomon JM; Pasupuleti R; Xu L; McDonagh T; Curtis R; DiStefano PS; Huber LJ
    Mol Cell Biol; 2006 Jan; 26(1):28-38. PubMed ID: 16354677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation.
    Barber MF; Michishita-Kioi E; Xi Y; Tasselli L; Kioi M; Moqtaderi Z; Tennen RI; Paredes S; Young NL; Chen K; Struhl K; Garcia BA; Gozani O; Li W; Chua KF
    Nature; 2012 Jul; 487(7405):114-8. PubMed ID: 22722849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT7-mediated ATM deacetylation is essential for its deactivation and DNA damage repair.
    Tang M; Li Z; Zhang C; Lu X; Tu B; Cao Z; Li Y; Chen Y; Jiang L; Wang H; Wang L; Wang J; Liu B; Xu X; Wang H; Zhu WG
    Sci Adv; 2019 Mar; 5(3):eaav1118. PubMed ID: 30944854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation.
    Shan X; Fu YS; Aziz F; Wang XQ; Yan Q; Liu JW
    PLoS One; 2014; 9(12):e115401. PubMed ID: 25521755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of H3K18 deacetylation of Sirt7 by Myb-binding protein 1a (Mybbp1a).
    Karim MF; Yoshizawa T; Sato Y; Sawa T; Tomizawa K; Akaike T; Yamagata K
    Biochem Biophys Res Commun; 2013 Nov; 441(1):157-63. PubMed ID: 24134843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel protein-protein interactions of TPPII, p53, and SIRT7.
    Nahálková J
    Mol Cell Biochem; 2015 Nov; 409(1-2):13-22. PubMed ID: 26169984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel chalcone polyphenol inhibits the deacetylase activity of SIRT1 and cell growth in HEK293T cells.
    Kahyo T; Ichikawa S; Hatanaka T; Yamada MK; Setou M
    J Pharmacol Sci; 2008 Nov; 108(3):364-71. PubMed ID: 19008647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in roles and mechanisms of deacetylase SIRT7].
    Li L; Dong Z; Yang J; Li Q; Lei Q; Mao J; Yang L; Cui H
    Sheng Wu Gong Cheng Xue Bao; 2019 Jan; 35(1):13-26. PubMed ID: 30756531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
    Lara E; Mai A; Calvanese V; Altucci L; Lopez-Nieva P; Martinez-Chantar ML; Varela-Rey M; Rotili D; Nebbioso A; Ropero S; Montoya G; Oyarzabal J; Velasco S; Serrano M; Witt M; Villar-Garea A; Imhof A; Mato JM; Esteller M; Fraga MF
    Oncogene; 2009 Feb; 28(6):781-91. PubMed ID: 19060927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle.
    Lu YF; Xu XP; Lu XP; Zhu Q; Liu G; Bao YT; Wen H; Li YL; Gu W; Zhu WG
    Oncogene; 2020 Jun; 39(24):4650-4665. PubMed ID: 32404984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.